sponsored
PatientsVille.com Logo

PatientsVille

White Blood Cells Urine Positive Medical Research Studies

Up-to-date List of White Blood Cells Urine Positive Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest White Blood Cells Urine Positive Medical Research Studies

Rank Status Study
1 Recruiting Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Conditions: Burkitt Lymphoma;   Diffuse Large B-cell Lymphoma, c-MYC Positive;   Plasmablastic Lymphoma
Interventions: Drug: EPOCH-R;   Drug: EPOCH-RR
Outcome Measure: PFS, EFS and OS
2 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
Outcome Measures: Safety, survival of transferred cells.;   Changes in immune and viral parameters (CD4, Plasma HIV levels)
3 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
Outcome Measures: This is a non-randomized, single arm pilot study of 10 participants to investigate the effect of interferon alpha on HIV-1 production in HIV-infected individuals with HIV-1 RNA levels of & lt; 50 copies/mL.;   Investigate HIV-1 genetic variation in individuals undergoing interferon therapy.;   Investigate the safety and tolerability of PEG INF 2b in HIV-1 infected individuals taking FDA-approved antiretrovirals in combinations recommended by Department of Health and Human Services (DHHS) guidelines.
4 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC),;   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
Outcome Measure: The primary endpoint of this study will be determination of a discretediagnosis of an infecting agent, an underlying susceptibility trait, or both.
5 Recruiting Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention: Drug: sirolimus
Outcome Measure: Assess safety of sirolimus in patients with eosinophilic gastrointestinal disorders.
6 Recruiting Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics
Condition: Lyme Disease
Intervention:
Outcome Measures: Long term outcome;   Immunological markers;   Biomarkers
7 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
Outcome Measures: The evaluation of adverse events to determine the safety and tolerability of rituximab in subjects with anticytokine autoantibody-associated diseases who are refractory to conventional treatment.;   Evaluation of changes in autoantibody titers in response to rituximab treatment.;   Assessment of the effects of rituximab on autoantibody-mediatedclinical disease.;   The measurement of both qualitative and quantitative differences in antibody composition and immune function after treatment with rituximab.
8 Recruiting Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
Conditions: Immunodeficiency;   Mycobacterial Infection;   Opportunistic Infection
Intervention:
Outcome Measure:
9 Recruiting Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Condition: Hepatitis C
Intervention:
Outcome Measure:
10 Recruiting Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Conditions: Myelodysplastic Syndrome;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Acute Leukemia;   Multiple Myeloma
Interventions: Biological: Rituximab;   Drug: Conditioning Chemotherapy;   Drug: TMS;   Drug: FLAG;   Drug: EPOCH-F;   Procedure: Hematopoietic Stem Cell Transplant;   Drug: Palifermin
Outcome Measures: For Phase I:To assess the safety and tolerability;   For Phase II portion: to determine the incidence of chronic GVHD
11 Recruiting Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
Conditions: Myelokathexis;   WHIMS;   Neutropenia;   Warts
Interventions: Drug: Plerixafor;   Drug: G-CSF
Outcome Measures: The primary endpoint is infection severity, which is measured as a composite of multiple weighted parameters according to rules defined in Appendix D of the protocol.;   Component measures of infections; incidence and duration of infections, fevers, antibiotic treatments, and hospitalization.;   Control of warts as defined by at least a 50% reduction in numbers, areas or size of existing warts and number of new warts.;   Blood count and immunological parameters.
12 Recruiting Collection of Lung Fluid and Tissue Samples for Research
Conditions: Mycobacterium Infections, Atypical;   Granulomatous Disease, Chronic;   Job's Syndrome;   Influenza, Human
Intervention:
Outcome Measure:
13 Recruiting Study of Mycobacterial Infections
Conditions: Atypical Mycobacterium Infections;   Cystic Fibrosis;   Job's Syndrome
Intervention:
Outcome Measure:

These studies may lead to new treatments and are adding insight into White Blood Cells Urine Positive etiology and treatment.

A major focus of White Blood Cells Urine Positive research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss White Blood Cells Urine Positive